High mortality rates in conservatively managed patients with acute coronary syndrome

Scandinavian Cardiovascular Journal

Volumn 40, Issue 3, 2006, Pages 137-144

  Aune, Erlend ^a   Hjelmesæth, Jøran ^a   Fox, Keith A A ^b   Endresen, Knut ^c   Otterstad, Jan Erik ^a  

^a VESTFOLD HOSPITAL TRUST   (Norway)

^b Cardiovascular Research Unit   (United Kingdom)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute coronary syndrome; Cohort studies; Coronary disease; Mortality; Myocardial infarction; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; STATINE DERIVATIVE; TENECTEPLASE; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONSERVATIVE TREATMENT; CORONARY REPERFUSION; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; SURVIVAL RATE; SURVIVAL TIME; THORAX PAIN; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CHEST PAIN; CORONARY DISEASE; DRUG THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PROSPECTIVE STUDIES;

EID: 33748339190     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430600699889     Document Type: Article

References (21)

1. The joint European Society of Cardiology/American College of Cardiology Committee. (2000) Myocardial infarction redefined - A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for redefinition of myocardial infarction Eur Heart J., 21, pp. 1502-13.
2. Bertrand, ME and Simoons, ML and Fox, KA and Wallentin, LC and Hamm, CV and McFadden, E and (2002) Management of acute coronary syndromes in patients presenting without ST-segment elevation Eur Heart J., 23, pp. 1809-40.
3. The clopidogrel in unstable angina to prevent recurrent events trial investigators. (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation New Engl J Med., 345, pp. 494-502.
4. Otterstad, JE and Platou, ES and Mangschau, A and Endresen, K. (2002) Hjerteinfarkt. Diagnostikk og behandling Hjerteforum, 15 Suppl 3.
5. Fibrinolytic Therapy Trialists' (FTT) Collaboration Group. (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and morbidity results from all randomised trials of more than 1000 patients Lancet. 343, pp. 311-22.
6. Van de Werf, F and Ardissino, D and Betriu, A and Cokkinos, DV and Falk, E and Fox, KA and (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J. 24, pp. 28-66.
7. Keeley, EC and Boura, JA and Grines, CL. (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials Lancet, 361, pp. 13-20.
8. Fox, KA and Goodman, SG and Klein, W and Brieger, D and Steg, PG and Dabbous, O and (2002) Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE) Eur Heart J. 23, pp. 1177-89.
9. Hjortshøj, S and Otterstad, JE and Lindahl, B and Danielsen, R and Pulkki, K and Ravkilde, J. (2005) Biochemical diagnosis of myocardial infarction evolves toward ESC/ACC consensus: Experiences from the Nordic countries Scand Cardiovasc J., 39, pp. 159-66.
10. Poole-Wilson, PA and Lubsen, J and Kirwan, BA and van Dalen, FJ and Wagener, G and Danchin, N and (2004) Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): Randomised controlled trial Lancet., 364, pp. 849-57.
11. Terkelsen, CJ and Lassen, JF and Nørgaard, BL and Gerds, JC and Jensen, T and Gøtzsche, LB and (2005) Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: Observations from an unselected cohort Eur Heart J., 26, pp. 18-26.
12. Bjorklund, E and Lindahl, B and Stenestrand, U and Swahn, E and Dellborg, M and Pehrsson, K and (2004) Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial Am Heart J. 148, pp. 566-73.
13. Hasdai, D and Behar, S and Wallentin, L and Danchin, N and Gitt, AK and Boersma, E and (2002) A prospective survey of the characteristics, treatment and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Study of Acute Coronary Syndromes (Euro Heart Survey ACS) Eur Heart J. 23, pp. 1190-1201.
14. Carruthers, KF and Dabbous, OH and Flather, MD and Starkey, I and Jacob, A and Macleod, D and (2005) Contemporary management of acute coronary syndromes: Does the practice match the evidence? The global registry of acute coronary events (GRACE) Heart. 91, pp. 290-8.
15. Sinnaeve, P and Alexander, J and Belmans, A and Bogaerts, K and Langer, A and Diaz, R and (2003) One year follow-up of the ASSENT-2 trial: A double-blinded, randomised comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction Am Heart J. 146, pp. 27-32.
16. Lincoff, AM and Califf, RM and Van de Werf, F and Willerson, JT and White, HD and Armstrong, PW and (2002) Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomised trial JAMA., 288, pp. 2130-5.
17. Otterstad, JE and St John Sutton, MG and Froeland, GS and Holme, I and Skjaerpe, T and Hall, C. (2002) Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function Eur Heart J., 23, pp. 1011-20.
18. Eagle, KA and Goodman, SG and Avezum, A and Budaj, A and Sullivan, CM and Lopez-Sendon, J and (2002) Practice variations and missed opportunities for reperfusion in ST-segment-elevation myocardial infraction: Findings from the Global Registry of Acute Coronary Events (GRACE) Lancet., 359, pp. 373-7.
19. De Backer, G and Ambrosioni, E and Borch-Johnsen, K and Brotons, C and Cifkova, R and Dallongeville, J and (2003) European guidelines on cardiovascular disease prevention in clinical practice Eur Heart J., 24, pp. 1601-10.
20. Fox, KA and Poole-Wilson, PA and Clayton, TC and Henderson, RA and Shaw, TR and Wheatley, DJ and (2005) 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: The British Heart Foundation RITA 3 randomised trial Lancet., 366, pp. 914-20.
21. Eagle, KA and Lim, MJ and Dabbous, OH and Pieper, KS and Goldberg, RJ and Van de Werf, F and (2004) A validated prediction model for all forms of acute coronary syndrome: Estimating the risk of 6-month postdischarge death in an international registry JAMA.;, 291, pp. 2727-33.